Target intelligence / Profile preview

Transmembrane protein 214 (TMEM214)

Target
TMEM214
Molecular classification
Transmembrane protein, Endoplasmic reticulum membrane protein, Apoptosis mediator, Other (not a typical receptor, enzyme, or transporter)
01

Overview

Transmembrane protein 214 (TMEM214) is a human protein localized primarily to the outer membrane of the endoplasmic reticulum, where it functions as a critical mediator of ER stress-induced apoptosis. TMEM214 achieves this role through a constitutive association and anchoring of procaspase 4, which is then activated during cellular stress resulting in apoptosis. Overexpression of TMEM214 induces apoptosis, while knockdown inhibits ER stress-induced apoptosis, confirming its essential role in cell death triggered by accumulation of misfolded proteins and ER stress. TMEM214 contains two transmembrane domains at its C-terminal region and a cytoplasmic N-terminal region important for its interaction with procaspase 4. While it is implicated in muscle diseases and may play a role in cellular responses related to cancer and tissue homeostasis, there are no established drugs, mechanisms, or biomarkers directly targeting TMEM214 clinically, nor are there reported safety concerns in therapeutic contexts.

Other names
TMEM214PP446FLJ20254transmembrane protein 214TM214_HUMAN
02

Mechanism of action

Anchoring procaspase 4 to the ER outer membrane. Facilitating caspase 4 activation in response to ER stress.

03

Biological functions

ApoptosisER stress-induced cell deathAnchoring and recruitment of procaspase 4Cellular signaling (within apoptotic pathways)
04

Disease associations

Myopathy, X-linked, with postural muscle atrophyEmery-Dreifuss muscular dystrophy 7, autosomal dominantCancer

Beyond the preview

Go deeper on Transmembrane protein 214 (TMEM214).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 214 (TMEM214).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call